Establishment of a prediction method for premature rupture of membranes in term pregnancy using active ceruloplasmin in cervicovaginal secretion as a clinical marker

Journal of Obstetrics and Gynaecology Research

Volumn 31, Issue 5, 2005, Pages 421-426

  Ogino, Mitsuharu ^a   Hiyamuta, Shuichi ^b   Takatsuji Okawa, Masako ^a   Tomooka, Yasuhiro ^b   Minoura, Shigeki ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

Active ceruloplasmin; Cervicovaginal secretion; Premature rupture of membranes

Indexed keywords

CERULOPLASMIN;

ADULT; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; INCIDENCE; MAJOR CLINICAL STUDY; PERINATAL CARE; PREDICTION; PREMATURE FETUS MEMBRANE RUPTURE; RECEIVER OPERATING CHARACTERISTIC; RELIABILITY; STATISTICAL ANALYSIS; UTERINE CERVIX MUCUS; WESTERN BLOTTING;

BIOLOGICAL MARKERS; CERULOPLASMIN; CERVIX MUCUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; HUMANS; IMMUNOBLOTTING; PREDICTIVE VALUE OF TESTS; PREGNANCY; ROC CURVE;

EID: 27744531862     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2005.00313.x     Document Type: Article

References (28)

1. Murtha AP, Greig PC, Jimmerson CE, Roitman-Johnson B, Allen J, Herbert WN. Maternal serum interleukin-6 concentrations in patients with preterm premature rupture of membranes and evidence of infection. Am J Obstet Gynec 1996; 175: 966-969.
2. Gomez R, Romero R, Galasso M, Behnke E, Insunza A, Cotton DB. The value of amniotic fluid interleukin-6, white blood cell count, and Gram stain in the diagnosis of microbial invasion of the amniotic cavity in patients at term. Am J Reprod Immunol 1994; 32: 200-210.
3. Steinborn A, Gätje R, Krämer M, Kühnert M, Halberstadt E. [Cytokines in the diagnosis of amniotic infection syndrome.] Z Geburtshilfe Perinatol 1994; 198: 1-5 (in German).
4. Sang QA. Specific proteolysis of ceruloplasmin by leukocyte elastase. Biochem Mol Biol Int 1995; 37: 573-581.
5. Raffi RO, Moghissi KS, Sacco AG. Proteins in human vaginal fluid. Fertil Steril 1977; 12: 1345-1348.
6. Frieden E. Caeruloplasmin: A multi-functional metalloprotein of vertebrate plasma. In: Ciba Foundation Symposium 79. Biological roles of copper. New York: Elsevier, 1980; 93-124.
7. Hiyamuta S, Shimizu K, Aoki T. Early diagnosis of Wilson's disease. Lancet 1993; 342: 56-57.
8. Ogino M, Hiyamuta S, Kadota A, Io Y, Hanazono M. Active ceruloplasmin in cervicovaginal secretions: Its association with term premature rupture of the membranes. Clin Chem 1999; 45: 2019-2022.
9. Davis BJ. Disc electrophoresis-II method and application to human serum proteins. Ann NY Acad Sci 1964; 121: 404.
10. Owen OA, Smith HG. Detection of caeruloplasmin after zone electrophoresis. Clin Chim Acta 1961; 6: 641-644.
11. Köhler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975; 256: 495-197.
12. Hiyamuta S, Ito K. Monoclonal antibody against the active site of caeruloplasmin and the ELISA system detecting active caeruloplasmin. Hybridoma 1994; 13: 139-141.
13. Varner MW. Ceruloplasmin and preterm rupture of the membranes. Clin Chem 1999; 45: 1887-1888.
14. Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease: A public health perspective. MMWR Recomm Rep 1996; 45(RR 7): 1-24.
15. Ramadori G, Van Damme J, Reider H, Meyer zum Buschenfeld KH. Interleukin-6, the third mediator of acute-phase reaction, modulates hepatic protein synthesis in human and mouse. Comparison with interleukin-1 beta and tumor necrosis factor-alpha. Eur J Immunol 1988; 18: 1259-1264.
16. French JI, McGregor JA. The pathology of premature rupture of membranes. Semin Perinatol 1996; 20: 344-368.
17. Nemet K, Simonovits I. The biological role of lactoferrin. Haematol Budap 1987; 24: 457-460.
18. Arnold RR, Cole MF, McGhee JR. A bactericidal effect for human lactoferrin. Science 1977; 197: 263-265.
19. Koivuranta VP, Banda D, Goldstein IM. Bacterial-lipopolysaccharide- induced release of lactoferrin from polynuclear leucocytes: Role of monocyte-derived tumor necrosis factor alpha. Infect Immunol 1987; 55: 2956-2961.
20. Leirisalo-Repo M. The present knowledge of the inflammatory process and the inflammatory mediators. Pharmacol Toxicol 1994; 75(Suppl. 2): 1-3.
21. Bazan NG, de Abreu MT, Bazan HE, Belfort R Jr. Arachidonic acid cascade and platelet-activating factor in the network of eye inflammatory mediators: Therapeutic implication in uveitis. Int Ophthalmol 1990; 14: 335-344.
22. Martynenko LD, Shepelev AP, Aleshukina AV. The effect of modulators of free- radical oxidation on the functional activity of phagocytes. Z Mikrobiol Epidermiol Immunobiol 1990; 10: 113-117.
23. Kurki T, Ylikorkala O. Prevention of preterm birth. Fetal Matern Med Rev 1993; 5: 191-202.
24. Andrews WW, Goldenberg RL, Hauth JC. Preterm labor: Emerging role of genital tract infections. Infect Agents Dis 1995; 4: 196-211.
25. ACOG Technical Bulletin. Preterm labor. Number 206 - June 1995. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 1995; 50: 303-313.
26. Shimoya K, Matsuzaki N, Taniguchi T et al. Interleukin-8 in cord sera: A sensitive and specific marker for the detection of preterm chorioamnionitis. J Infect Dis 1992; 165: 957-960.
27. Lockwood CJ. Recent advances in elucidating the pathogenesis of preterm delivery, the detection of patients at risk, and preventative therapies. Curr Opin Obstet Gynecol 1994; 6: 7-18.
28. Peaceman AM, Andrews WW, Thorp JM et al. Fetal fibronectin as a predictor of preterm birth in patients with symptoms: A multicenter trial. Am J Obstet Gynecol 1997; 177: 13-18.